HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsuyoshi Nakai Selected Research

satraplatin (JM 216)

1/2011Modulation of oxidative DNA damage and DNA-crosslink formation induced by cis-diammine-tetrachloro-platinum(IV) in the presence of endogenous reductants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tsuyoshi Nakai Research Topics

Disease

3Osteoarthritis
07/2023 - 01/2003
2Thrombocytopenia (Thrombopenia)
05/2024 - 04/2024
2Neoplasms (Cancer)
04/2024 - 01/2011
2Wounds and Injuries (Trauma)
05/2023 - 05/2022
2Infections
06/2022 - 05/2022
2Severe Acute Respiratory Syndrome
06/2022 - 05/2022
2Cognitive Dysfunction
05/2021 - 08/2013
2Virus Diseases (Viral Diseases)
10/2018 - 05/2014
2Pain (Aches)
01/2013 - 01/2013
2Hip Osteoarthritis (Coxarthrosis)
05/2007 - 10/2002
2Bone Resorption
07/2003 - 01/2003
1Colorectal Neoplasms (Colorectal Cancer)
05/2024
1Liver Cirrhosis (Hepatic Cirrhosis)
05/2024
1COVID-19 related adult multisystem inflammatory disease
05/2023
1Fever (Fevers)
06/2022
1COVID-19
06/2022
1Diabetes Mellitus
05/2022
1Mental Disorders (Mental Disorder)
02/2022
1Alzheimer Disease (Alzheimer's Disease)
05/2021
1Obesity
06/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2013
1Memory Disorders (Memory Loss)
08/2013
1Postoperative Pain
05/2007
1Osteoporosis
07/2003

Drug/Important Bio-Agent (IBA)

2Diclofenac (SR 38)FDA LinkGeneric
01/2013 - 01/2013
1Capecitabine (Xeloda)FDA Link
05/2024
1AlbuminsIBA
05/2024
1Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2024
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2024
1GemcitabineFDA Link
04/2024
1Cisplatin (Platino)FDA LinkGeneric
04/2024
1Hemoglobins (Hemoglobin)IBA
04/2024
1Immunoglobulin G (IgG)IBA
05/2022
1Immunoglobulin M (IgM)IBA
05/2022
1CoagulaseIBA
05/2022
1C-Reactive ProteinIBA
05/2022
1AntibodiesIBA
05/2022
1Messenger RNA (mRNA)IBA
02/2022
1Reelin ProteinIBA
02/2022
1Biomarkers (Surrogate Marker)IBA
05/2021
1Poly I-CIBA
10/2018
1AcidsIBA
05/2014
1FlavonoidsIBA
08/2013
1nobiletinIBA
08/2013
1PlatinumIBA
01/2011
1Reducing AgentsIBA
01/2011
1satraplatin (JM 216)IBA
01/2011
1Therapeutic UsesIBA
07/2003
1Etidronic Acid (HEDP)FDA LinkGeneric
07/2003
1Matrix Metalloproteinases (MMPs)IBA
10/2002

Therapy/Procedure

5Hip Replacement Arthroplasty (Total Hip Replacement)
07/2023 - 01/2003
3Therapeutics
05/2024 - 07/2003
2Canes (Cane)
01/2013 - 01/2013
1Adjuvant Chemotherapy
05/2024
1Combination Drug Therapy (Combination Chemotherapy)
04/2024
1Drug Therapy (Chemotherapy)
04/2024
1Platelet Transfusion (Blood Platelet Transfusions)
04/2024
1Thoracoscopes
05/2023
1Surgical Instruments (Clip)
05/2023
1Orthopedic Procedures
06/2022
1Contraindications
06/2018
1Injections
01/2013
1Knee Replacement Arthroplasty (Total Knee Replacement)
01/2013
1Epidural Anesthesia
05/2007